Scientific publications

CNS Neuroscience & Therapeutics, 2026

Olink Proteomics Reveals CCL2 Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High‐Altitude Migrants Via CCR2 / NF ‐ κB ‐Mediated Blood–Brain Barrier Disruption

Huang R., Gao L., Dai Y. et al.

Open Forum Infectious Diseases, 2026

Proteomic Profile After Intervention With Eplerenone Among Persons With HIV

Murthy A., Kolossváry M., Walpert A. et al.

Pulmonology, 2026

Plasma proteomic signatures linking preserved ratio impaired spirometry to cardiometabolic diseases and multimorbidity: A longitudinal cohort study

He L., Liu C., Zhao H. et al.

Circulation: Genomic and Precision Medicine, 2026

Associations of the ICAM1 p.K56M HFpEF Risk Variant With Pericardial Adiposity and the Inflammatory Proteome

Aneja A., Culler K., Ding J. et al.

Frontiers in Immunology, 2026

Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia

Wang J., Pan S., Xiong C. et al.

Clinical & Experimental Allergy, 2026

Effects of Common Food Additives Kappa‐, Iota‐ and Lambda‐Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption

Sun N., Pat Y., Babayev H. et al.

British Journal of Cancer, 2026

Significance of tumor infiltrating granulocytes and neutrophil extracellular traps in colorectal cancer

Rahkola O., Tuomisto A., Elomaa H. et al.

Journal of Proteome Research, 2026

Stability-Based Machine Learning Identifies a Minimal Two-Protein Serum Signature for Early Silicosis

Chu X., Li Y., Wang F. et al.

Translational Psychiatry, 2026

Plasma proteome profiling identifies novel biomarkers and predictors for schizophrenia

Wu S., Guo X., Jia T. et al.

Aging Cell, 2026

Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease

Tavenier J., Holm N., Kallemose T. et al.

Medicine, 2026

Association of genetically determined plasma hepatocyte growth factor with lung cancer and its subtypes: Mendelian randomization and mediation analysis

Xu F., Xu Q., Yu J. et al.

Journal of Alzheimer's Disease Reports, 2026

Exploring potential genetic correlation and causality between cathepsins and neurodegenerative diseases: Insight from Mendelian randomization analyses

Shu H., He R., Zhu Z. et al.

Signal Transduction and Targeted Therapy, 2026

Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation

Lambertucci F., Motiño O., Nogueira-Recalde U. et al.

European Journal of Applied Physiology, 2026

Acute responses of inflammatory markers, glucose, and myoglobin in blood following neuromuscular electrical stimulation

Flodin J., Amiri P., Reitzner S. et al.

Nature Communications, 2026

Macrophage Gsα promotes NLRP3 stability and its intervention attenuates abdominal aortic aneurysm in male mice

He L., Qin X., Ren Q. et al.

The Journal of Headache and Pain, 2026

Plasma proteomics identifies proteins and pathways associated with incident migraine in 50,668 adults

Hong Y., Chen F., Mi Y. et al.

Molecular Medicine, 2026

Pathway-level profiling of the sepsis proteome reveals immune and transcriptional dysregulation

Van Nynatten L., Tweddell D., Daley M. et al.

Nature Cardiovascular Research, 2026

Large-scale identification of protein biomarkers and therapeutic targets in heart and brain disease

Wu C., Li D., Khetarpal S. et al.

MedComm, 2026

Identification of Blood Pressure‐Associated Metabolites by Integrating Metabolomic and Genetic Analysis

Liu Y., Cheng C., Pan X. et al.

Yonsei Medical Journal, 2026

Statin-Associated Hepatotoxicity Linked to CASP8 Polymorphisms: Mechanistic Insights from Proteomic Analysis

Lee D., Park Y., Choi S. et al.